A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer CellsNicola Landi, Antimo Di Maro|Toxins|2023Cited by 6